Research
July 7, 2025
OnCore Clinical Trials System is Live
The Winthrop P. Rockefeller Cancer Institute launched July 1 the Advarra OnCore Clinical Trials Management System (CTMS), a powerful new platform that will enhance cancer clinical trials oversight and support cutting-edge research across the University of Arkansas for Medical Sciences (UAMS). The $2.4 million investment by the Cancer Institute places UAMS among the nation’s leading…
June 26, 2025
College Students Explore Cancer Research at Arkansas INBRE Workshop
Undergraduates from 14 schools across the country had the opportunity to explore the field of cancer research at a UAMS workshop sponsored by the Arkansas INBRE (IDeA Networks of Biomedical Research Excellence). Held May 28 in the UAMS Library, the “Bench to Bedside: Breakthroughs in Cancer Research and Therapy Workshop” attracted nearly 30 students interested in…
June 5, 2025
Arkansas’ Leading Cancer Researchers Gather at Winthrop P. Rockefeller Cancer Institute Retreat
In a strong showing as the state’s leader in cancer research, the Winthrop P. Rockefeller Cancer Institute hosted its annual research retreat May 7 for scientists across the University of Arkansas for Medical Sciences (UAMS). Held at the Robinson Center Grand Ballroom in downtown Little Rock, the daylong event served as an opportunity for researchers…
April 22, 2025
UAMS Winthrop P. Rockefeller Cancer Institute Scientists Uncover New Opportunities for Targeted Cancer Therapies
Molecular Cell publishes UAMS comprehensive structural biology study of MCL-1:BAK complex found in most cancers A research team led by UAMS Winthrop P. Rockefeller Cancer Institute scientist, Tudor Moldoveanu, Ph.D., has uncovered novel insights into one of the body’s most fundamental processes impacting the development of cancer. Known as apoptosis, the research on the process…
March 31, 2025
NIH Awards UAMS Nearly $3 Million to Study DNA Structures that Could Impact Cancer Treatment
LITTLE ROCK — University of Arkansas for Medical Sciences (UAMS) researcher Kevin Raney, Ph.D., has been awarded a five-year, $2.99 million grant from the National Institutes of Health (NIH) to study unusual DNA structures called quadruplexes, which may act like natural drugs by binding to key proteins involved in disease. The grant from the NIH…
March 6, 2025
UAMS Winthrop P. Rockefeller Cancer Institute Scientist Awarded $1.9 Million to Study Air Pollution, Breast Cancer
A researcher at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has received a $1.9 million grant from the National Institute of Environmental Health Sciences (NIEHS) to study the role of environmental exposures in the development of early onset breast cancer in Arkansas women. Ping-Ching Hsu, Ph.D., an…
October 15, 2024
UAMS Establishes Proteomics Center of Excellence in Little Rock with Thermo Fisher Scientific
The University of Arkansas for Medical Sciences (UAMS) announced the launch of the Thermo Fisher Scientific Center of Excellence for Proteomics at UAMS — the first and only academic-industry partnership of its kind in the United States. The world leader in serving science, Thermo Fisher Scientific, entered into a formal agreement with the IDeA National…
October 14, 2024
Symposium Showcases Promising Research Aimed at Reducing Cancer Therapy Side Effects
What is worse? Cancer or cancer treatment? Ask any patient treated with chemotherapy, and the answer may be the treatment. Common side effects of chemotherapy include pain, fatigue, hair loss, mouth sores, bowel issues as well as nerve, muscle, cell and organ damage. And that’s just chemotherapy. Conventional X-ray radiation, a treatment needed by half…
October 8, 2024
Marius Nagalo, Ph.D., First at UAMS to Receive NIH New Innovator Award
LITTLE ROCK — A researcher at the Winthrop P Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), Marius Nagalo, Ph.D., has received the prestigious New Innovator Award from the National Institutes of Health (NIH).
July 25, 2024
UAMS’ Michael Birrer, M.D., Ph.D., Publishes Study Results in JAMA Oncology on Treatment for Incurable Cervical Cancer
The results of an international clinical trial led by Michael Birrer, M.D., Ph.D., director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), on the use of a novel bispecific antibody for women with recurrent or metastatic cervical cancer were published today in JAMA Oncology. Cervical cancer is…
Next page